is tirzepatide a glp-1 receptor agonist comparing cardiovascular and kidney outcomes with vs. agonists GLP1 Agonists vs SGLT2-I in Preventing CKD in T2DM: An Interview – AJKD Blog Beyond glycemia: Comparing tirzepatide to – The Landscape Of GLP-1 Receptor

We recommend bloodwork at baseline, 3 months, and 6 months

Do not use if you or a family member has a history of: Medullary thyroid carcinoma (MTC) Multiple endocrine neoplasia syndrome type 2 (MEN 2) *This content is for informational purposes only and is not a substitute for professional medical advice or diagnosis

One point worth underlining: those trials studied the branded, FDA-approved products under controlled conditions

Hydration GLP-1s keep you fuller longer, so it may be challenging to stay hydrated while making sure you are consuming adequate amounts of nutrients

Semaglutide and tirzepatide have been prescribed to millions of patients for diabetes and obesity

Long-term effects of GH therapy in adult patients with Prader-Willi syndrome: a longitudinal study